For more than two years, the clock ran down toward March 29, the day Prime Minister May pledged Britain would leave the European Union. As the drama rolls on, the costs mount from the Brexit day that wasn’t.
Streamlining the pharmaceutical supply chain and getting more generic drugs to market would help consumers who can’t afford prescriptions, the head of the U.S. Senate’s special committee on aging says.
A nonprofit founded to address a pressing U.S. health-care problem by manufacturing much-needed drugs that have fallen into short supply, or that are too expensive, will start out with a different approach: buying the drugs from pharmaceutical companies.
McKesson Corp., one of the largest U.S. drug distributors, sent pharmacies prescription opioids that had been removed from their bottles and replaced with over-the-counter painkillers, the Food and Drug Administration says.
Concerns about quality control and data integrity have focused on companies in India and China, where more and more ingredients used in medicine for the U.S. are being made. But those concerns aren’t limited to overseas factories, according to a year-long investigation into FDA’s regulation of the generic-drug industry.